MedPath
HSA Approval

CEFAZOLIN-AFT POWDER FOR INJECTION 1G/VIAL

SIN14480P

CEFAZOLIN-AFT POWDER FOR INJECTION 1G/VIAL

CEFAZOLIN-AFT POWDER FOR INJECTION 1G/VIAL

January 13, 2014

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DB04

cefazolin

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

QILU PHARMACEUTICAL CO., LTD

Active Ingredients

CEFAZOLIN SODIUM 1.048 g/vial EQV CEFAZOLIN BASE

1 g/vial

Cefazolin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.